mSystems
(Jun 2021)
Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021
Thomas Wilton,
Erika Bujaki,
Dimitra Klapsa,
Manasi Majumdar,
Maria Zambon,
Martin Fritzsche,
Ryan Mate,
Javier Martin
Affiliations
Thomas Wilton
Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
Erika Bujaki
Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
Dimitra Klapsa
Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
Manasi Majumdar
Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
Maria Zambon
Respiratory Virology and Polio Reference Service, Public Health England, London, UK
Martin Fritzsche
Division of Analytical and Biological Sciences, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
Ryan Mate
Division of Analytical and Biological Sciences, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
Javier Martin
ORCiD Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
DOI
https://doi.org/10.1128/mSystems.00353-21
Journal volume & issue
Vol. 6,
no. 3
Abstract
Read online
The recent appearance and growth of new SARS-CoV-2 variants represent a major challenge for the control of the COVID-19 pandemic. These variants of concern contain mutations affecting antigenicity, which raises concerns on their possible impact on human immune response to the virus and vaccine efficacy against them.
WeChat QR code
Close
